Characteristics | Value | |
---|---|---|
Response to preoperative chemotherapy | 0, 1/2, 3 | 69/15 |
Age | Years | 65 (30–77) |
Sex | F/M | 14/70 |
cT | 0/1/2/3/4 | 0/11/12/59/2 |
cN | 0/1/2/3 | 10/47/23/4 |
cM | 0/1 | 79/5 |
cStage | 0/1/2/3/4 | 0/3/22/54/5 |
pT | 0/1/2/3/4 | 4/23/19/29/9 |
pN | 0/1/2/3 | 29/28/16/11 |
pM | 0/1 | 79/5 |
pStage | 0/1/2/3/4 | 2/17/27/33/5 |
Differentiationa | Poor/moderate/well | 10/59/8 |
Lymphatic invasion | 0/1 | 31/53 |
Venous invasion | 0/1 | 59/25 |
Pretreatment serum CEAb | ng/ml | 2.53 (1–6) |
Pretreatment serum SCC antigenc | ng/ml | 1.46 (0.5–6.7) |